論文 - 森瀬 昌宏
-
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma 査読有り 国際誌
Kodama Yuta, Tanaka Ichidai, Sato Tatsuhiro, Hori Kazumi, Gen Soei, Morise Masahiro, Matsubara Daisuke, Sato Mitsuo, Sekido Yoshitaka, Hashimoto Naozumi
CANCER SCIENCE 112 巻 ( 9 ) 頁: 3520 - 3532 2021年9月
-
A multicenter cohort study of osimertinib compared with afatinib as first-line treatment for EGFR-mutated non-small-cell lung cancer from practical dataset: CJLSG1903 査読有り 国際誌
Ito K., Morise M., Wakuda K., Hataji O., Shimokawaji T., Takahashi K., Furuya N., Takeyama Y., Goto Y., Abe T., Kato T., Ozone S., Ikeda S., Kogure Y., Yokoyama T., Kimura M., Yoshioka H., Murotani K., Kondo M., Saka H.
ESMO OPEN 6 巻 ( 3 ) 2021年6月
-
Shiraishi, Y; Hata, A; Inui, N; Okada, M; Morise, M; Akiyoshi, K; Takeda, M; Watanabe, Y; Sugawara, S; Shinagawa, N; Kubota, K; Saeki, T; Tamura, T
JOURNAL OF CLINICAL ONCOLOGY 39 巻 ( 15 ) 2021年5月
-
IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1-Selected NSCLC 査読有り 国際共著 国際誌
Herbst R., De Marinis F., Giaccone G., Vergnenegre A., Barrios C., Morise M., Felip E., Oprean C., Kim Y., Andric Z., Mocci S., Enquist I., Komatsubara K., Mccleland M., Deng Y., Kuriki H., Villalobos M., Phan S., Spigel D., Jassem J.
JOURNAL OF THORACIC ONCOLOGY 16 巻 ( 3 ) 頁: S224 - S225 2021年3月
-
Lorlatinib in previously treated anaplastic lymphoma kinase-rearranged non-small cell lung cancer: Japanese subgroup analysis of a global study 査読有り 国際共著 国際誌
Seto Takashi, Hayashi Hidetoshi, Satouchi Miyako, Goto Yasushi, Niho Seiji, Nogami Naoyuki, Hida Toyoaki, Takahashi Toshiaki, Sakakibara-Konishi Jun, Morise Masahiro, Nagasawa Takashi, Suzuki Mie, Ohkura Masayuki, Fukuhara Kei, Thurm Holger, Peltz Gerson, Nishio Makoto
CANCER SCIENCE 111 巻 ( 10 ) 頁: 3726 - 3738 2020年10月
-
Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study 査読有り 国際誌
Nakano Takashi, Kuribayashi Kozo, Kondo Masashi, Morise Masahiro, Tada Yuji, Hirano Katsuya, Hayashi Morihiko, Tanaka Misa, Hirabayashi Masataka
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 2020年9月
-
Clinical burden of immune checkpoint inhibitor-induced pneumonitis 査読有り 国際誌
Sakamoto Koji, Fukihara Jun, Morise Masahiro, Hashimoto Naozumi
RESPIRATORY INVESTIGATION 58 巻 ( 5 ) 頁: 305 - 319 2020年9月
-
Primary Prophylaxis Indication for Docetaxel Induced Febrile Neutropenia in Elderly Patients with Non-Small Cell Lung Cancer 査読有り 国際誌
Matsui Akira, Morise Masahiro, Tanaka Ichidai, Ozone Sachiko, Matsuzawa Reiko, Koyama Junji, Hase Tetsunari, Hashimoto Naozumi, Sato Mitsuo, Hasegawa Yoshinori
CANCER INVESTIGATION 38 巻 ( 7 ) 頁: 424 - 430 2020年8月
-
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation 査読有り 国際誌
Tanaka Ichidai, Morise Masahiro, Miyazawa Ayako, Kodama Yuta, Tamiya Yutaro, Gen Soei, Matsui Akira, Hase Tetsunari, Hashimoto Naozumi, Sato Mitsuo, Hasegawa Yoshinori
CLINICAL LUNG CANCER 21 巻 ( 3 ) 頁: 273 - + 2020年5月
-
Reply to "Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With NoneSmall-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors" 査読有り 国際誌
Fukihara Jun, Sakamoto Koji, Koyama Junji, Ito Takayasu, Iwano Shingo, Morise Masahiro, Ogawa Masahiro, Kondoh Yasuhiro, Kimura Tomoki, Hashimoto Naozumi, Hasegawa Yoshinori
CLINICAL LUNG CANCER 21 巻 ( 3 ) 頁: E205 - E205 2020年5月
-
UHRF1, a Regulator of Methylation, as a Diagnostic and Prognostic Marker for Lung Cancer 査読有り 国際誌
Goto Daiki, Komeda Kazuki, Uwatoko Natsuki, Nakashima Moeka, Koike Mayu, Kawai Kaho, Kodama Yuta, Miyazawa Ayako, Tanaka Ichidai, Hase Tetsunari, Morise Masahiro, Hasegawa Yoshinori, Kawabe Tsutomu, Sato Mitsuo
CANCER INVESTIGATION 38 巻 ( 4 ) 頁: 240 - 249 2020年4月
-
Phase II, open-label, multicenter trial of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study 査読有り 国際誌
Shimokawa Mototsugu, Nosaki Kaname, Seto Takashi, Ohashi Kadoaki, Morise Masahiro, Horinouchi Hidehito, Sakakibara Jun, Murakami Haruyasu, Yano Seiji, Satouchi Miyako, Matsumoto Shingo, Goto Koichi, Yoh Kiyotaka
TRIALS 21 巻 ( 1 ) 2020年3月
-
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study 査読有り 国際誌
Okada Norio, Iwama Shintaro, Okuji Takayuki, Kobayashi Tomoko, Yasuda Yoshinori, Wada Eri, Onoue Takeshi, Goto Motomitsu, Sugiyama Mariko, Tsunekawa Taku, Takagi Hiroshi, Hagiwara Daisuke, Ito Yoshihiro, Suga Hidetaka, Banno Ryoichi, Hase Tetsunari, Morise Masahiro, Kanda Mitsuro, Yokota Kenji, Hashimoto Naozumi, Ando Masahiko, Fujimoto Yasushi, Nagino Masato, Kodera Yasuhiro, Fujishiro Mitsuhiro, Hibi Hideharu, Sone Michihiko, Kiyoi Hitoshi, Gotoh Momokazu, Ando Yuichi, Akiyama Masashi, Hasegawa Yoshinori, Arima Hiroshi
BRITISH JOURNAL OF CANCER 122 巻 ( 6 ) 頁: 771 - 777 2020年3月
-
Risk factors for pulmonary infection after diagnostic bronchoscopy in patients with lung cancer 査読有り 国際誌
Shimizu Takahiro, Okachi Shotaro, Imai Naoyuki, Hase Tetsunari, Morise Masahiro, Hashimoto Naozumi, Sato Mitsuo, Hasegawa Yoshinori
NAGOYA JOURNAL OF MEDICAL SCIENCE 82 巻 ( 1 ) 頁: 69 - 77 2020年2月
-
Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer 査読有り 国際誌
Nakagawa Kazuhiko, Hida Toyoaki, Nokihara Hiroshi, Morise Masahiro, Azuma Koichi, Kim Young Hak, Seto Takashi, Takiguchi Yuichi, Nishio Makoto, Yoshioka Hiroshige, Kumagai Toru, Hotta Katsuyuki, Watanabe Satoshi, Goto Koichi, Satouchi Miyako, Kozuki Toshiyuki, Koyama Ryo, Mitsudomi Tetsuya, Yamamoto Nobuyuki, Asakawa Takashi, Hayashi Morihiko, Hasegawa Wakako, Tamura Tomohide
LUNG CANCER 139 巻 頁: 195 - 199 2020年1月
-
Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study 査読有り 国際誌
Kobayashi Tomoko, Iwama Shintaro, Yasuda Yoshinori, Okada Norio, Okuji Takayuki, Ito Masaaki, Onoue Takeshi, Goto Motomitsu, Sugiyama Mariko, Tsunekawa Taku, Takagi Hiroshi, Hagiwara Daisuke, Ito Yoshihiro, Suga Hidetaka, Banno Ryoichi, Yokota Kenji, Hase Tetsunari, Morise Masahiro, Hashimoto Naozumi, Ando Masahiko, Fujimoto Yasushi, Hibi Hideharu, Sone Michihiko, Ando Yuichi, Akiyama Masashi, Hasegawa Yoshinori, Arima Hiroshi
JOURNAL FOR IMMUNOTHERAPY OF CANCER 8 巻 ( 2 ) 2020年
-
Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors 査読有り 国際誌
Fukihara Jun, Sakamoto Koji, Koyama Junji, Ito Takayasu, Iwano Shingo, Morise Masahiro, Ogawa Masahiro, Kondoh Yasuhiro, Kimura Tomoki, Hashimoto Naozumi, Hasegawa Yoshinori
CLINICAL LUNG CANCER 20 巻 ( 6 ) 頁: 442 - + 2019年11月
-
Potential for afatinib as an optimal treatment for advanced non-small cell lung carcinoma in patients with uncommon EGFR mutations 査読有り 国際誌
Tanaka Ichidai, Morise Masahiro, Kodama Yuta, Matsui Akira, Ozawa Naoya, Ozone Sachiko, Goto Daiki, Miyazawa Ayako, Hase Tetsunari, Hashimoto Naozumi, Sato Mitsuo, Hasegawa Yoshinori
LUNG CANCER 127 巻 頁: 169 - 171 2019年1月
-
eIF2 beta, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer 査読有り 国際共著 国際誌
Tanaka Ichidai, Sato Mitsuo, Kato Toshio, Goto Daiki, Kakumu Tomohiko, Miyazawa Ayako, Yogo Naoyuki, Hase Tetsunari, Morise Masahiro, Sekido Yoshitaka, Girard Luc, Minna John D., Byers Lauren A., Heymach John V., Coombes Kevin R., Kondo Masashi, Hasegawa Yoshinori
CANCER SCIENCE 109 巻 ( 6 ) 頁: 1843 - 1852 2018年6月
-
Safety and efficacy of diagnostic flexible bronchoscopy in very old patients with lung cancer
Okachi Shotaro, Imaizumi Kazuyoshi, Imai Naoyuki, Shimizu Takahiro, Hase Tetsunari, Morise Masahiro, Hashimoto Naozumi, Sato Mitsuo, Hasegawa Yoshinori
EUROPEAN GERIATRIC MEDICINE 9 巻 ( 2 ) 頁: 255-262 2018年4月